MyDoanh Chau

485 citations
9 papers · 378 indexed · h-index 7
Topics
Microbial Natural Products and Biosynthesis (4 papers)Cancer Treatment and Pharmacology (4 papers)Plant biochemistry and biosynthesis (4 papers)

In The Last Decade

MyDoanh Chau

9 papers receiving 362 citations

Peers

MyDoanh Chau
Comparison fields: 5 of 51
  • Molecular Biology 280
  • Pharmacology 222
  • Oncology 184
  • Organic Chemistry 43
  • Cell Biology 37
Replace Ryuichi Sekizawa with:
Ryuichi Sekizawa Japan
V. Möhrle Germany
Yahya Salma France
Andrew J. Kale United States
Janice Lau United States
Masatomi Iijima Japan
Seema Irani United States
Shining Loo Singapore
Katherine McArthur United States
Chayanid Ongpipattanakul United States
MyDoanh Chau relative to Ryuichi Sekizawa Japan Ryuichi Sekizawa's profile →
Citations per field
00.5×3.8×
Ryuichi Sekizawa · 1×
Citations per year

Countries citing papers authored by MyDoanh Chau

Since Specialization
Citations

This map shows the geographic impact of MyDoanh Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MyDoanh Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MyDoanh Chau more than expected).

Fields of papers citing papers by MyDoanh Chau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MyDoanh Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MyDoanh Chau. The network helps show where MyDoanh Chau may publish in the future.

Co-authorship network of co-authors of MyDoanh Chau

This figure shows the co-authorship network connecting the top 25 collaborators of MyDoanh Chau. A scholar is included among the top collaborators of MyDoanh Chau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MyDoanh Chau. MyDoanh Chau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 6
2 14
3 1
4 23
5
The imidazoacridinone, C-1311 (Symadex™): The first of a potent new class of FLT3 inhibitors
4
6 84
7 32
8 88
9 126

About MyDoanh Chau

MyDoanh Chau is a scholar working on Oncology, Pharmacology and Pharmacology, having authored 9 papers that have together received 378 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Plant biochemistry and biosynthesis (4 papers). The work is most often cited by research in Pharmacology (222 citations), Oncology (184 citations) and Molecular Biology (280 citations). MyDoanh Chau has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Rodney Croteau, Kevin D. Walker, Stefan Jennewein, Mark R. Wildung, Alfred M. Ajami, Robert M. Long, Robert L. Capizzi, Sun‐Young Chang, Hans-Christian Reinecker and Carmen Alonso. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026